Real-World Evidence in Oncology: Opportunities and Limitations

Massimo Di Maio; Francesco Perrone; Pierfranco Conte

doi:10.1634/theoncologist.2019-0647

Real-World Evidence in Oncology: Opportunities and Limitations

Oncologist. 2020 May;25(5):e746-e752. doi: 10.1634/theoncologist.2019-0647. Epub 2019 Dec 24.

Authors

Massimo Di Maio¹, Francesco Perrone², Pierfranco Conte³

Affiliations

¹ Department of Oncology, University of Turin; Ordine Mauriziano Hospital, Torino, Italy.
² Clinical Trial Unit, National Cancer Institute, IRCCS Fondazione Pascale, Napoli, Italy.
³ Department of Surgery, Oncology and Gastroenterology, University of Padova and Oncologia Medica 2, Istituto Oncologico Veneto, I.R.C.C.S., Padova, Italy.

Abstract

The analysis of real‐world evidence to answer clinical and policy‐relevant questions in the field of oncology has gained increased interest in recent years. This article highlights the strengths and weaknesses of the use of real‐world evidence in cancer care.

Keywords: Cancer treatments; Clinical trials; Real-world evidence.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Humans
Medical Oncology*